How have EPRX shares performed in 2024?

Eupraxia Pharmaceuticals' stock was trading at $2.72 on January 1st, 2024. Since then, EPRX stock has increased by 8.5% and is now trading at $2.95. View the best growth stocks for 2024 here .

When is Eupraxia Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our EPRX earnings forecast .

How were Eupraxia Pharmaceuticals' earnings last quarter?

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) posted its quarterly earnings data on Wednesday, May, 8th. The company reported ($0.21) EPS for the quarter.

How do I buy shares of Eupraxia Pharmaceuticals?

Shares of EPRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:EPRX

Eupraxia Pharmaceuticals (EPRX) Stock Price, News & Analysis

→ Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad)

Free EPRX Stock Alerts

$2.95

-0.03 (-1.01%)

(As of 05/16/2024 ET)

Compare

Today's Range: $2.95
▼
$2.98
50-Day Range: N/A
52-Week Range: $2.48
▼
$6.78

Volume: 16,203 shs
Average Volume: 19,244 shs
Market Capitalization: $80.48 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials SEC Filings Social Media

Get Eupraxia Pharmaceuticals alerts:

Ad InvestorPlace

Crypto Pioneer Says: “The last crypto bull market has begun.”

Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.

Click here if you’d like to learn more about these five cryptos…

About Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company. It focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Th company's lead product candidate includes EP-104IAR, for the treatment of pain due to osteoarthritis of the knee. Eupraxia Pharmaceuticals Inc. is based in VICTORIA, BC.

EPRX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

EPRX Stock News Headlines

May 14 at 7:00 AM | prnewswire.com

Eupraxia Pharmaceuticals to Present Initial Results from Ongoing Phase 1b Study of EP-104GI for the Treatment of Eosinophilic Esophagitis at Upcoming Digestive Disease Week Annual Meeting 2024

See More Headlines

Receive EPRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/08/2024
Today: 5/17/2024
Next Earnings (Estimated): 8/14/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:EPRX
CUSIP: N/A
CIK: 1581178
Web: N/A
Phone: N/A
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 27,282,000
Free Float: N/A
Market Cap: $80.48 million
Optionable: N/A
Beta: N/A

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Competitors

View All Competitors

EPRX Stock Analysis - Frequently Asked Questions

How have EPRX shares performed in 2024?: Eupraxia Pharmaceuticals' stock was trading at $2.72 on January 1st, 2024. Since then, EPRX stock has increased by 8.5% and is now trading at $2.95.
View the best growth stocks for 2024 here.
When is Eupraxia Pharmaceuticals' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024.
View our EPRX earnings forecast.
How were Eupraxia Pharmaceuticals' earnings last quarter?: Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) posted its quarterly earnings data on Wednesday, May, 8th. The company reported ($0.21) EPS for the quarter.
How do I buy shares of Eupraxia Pharmaceuticals?: Shares of EPRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:EPRX) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial